EMERGENCY:Seizure lasting more than 5 minutes, or status dystonicus in LGS or Dravet syndrome —call040-46324365immediately — 24 hours, 7 days— 24/7
Generalised Epilepsy: When Both Halves of the Brain Seize Together and Why Naming the Syndrome Correctly Is the Most Important Thing a Doctor Can Do
Generalised epilepsy is a common epilepsy type seen in India, including Juvenile Myoclonic Epilepsy (JME), Lennox-Gastaut syndrome, Dravet syndrome, Childhood Absence Epilepsy, and other syndromes that require completely different treatment approaches. At KIMS Neuroscience, Hyderabad, every epilepsy consultation begins with syndrome diagnosis because the wrong medication can actively worsen seizures.
Epilepsy in which seizures involve both brain hemispheres simultaneously from the very start
Juvenile Myoclonic Epilepsy (JME) — begins in adolescence, lifelong, but excellently controlled with the right medication
Focal epilepsy is the most common type in India, but generalised epilepsy accounts for a substantial share — often in children and adolescents
Carbamazepine, phenytoin, and gabapentin can worsen JME and Dravet syndrome — and carbamazepine and phenytoin are widely prescribed in India
Lennox-Gastaut syndrome · Dravet syndrome — treatment-resistant but manageable with the right combination
Corpus callosotomy at KIMS reduces drop attacks by 70–80% — life-changing injury prevention
Epilepsy · Neurology · Paediatric Neurology
040-44885000
Generalised epilepsy is epilepsy in which abnormal electrical discharges involve both brain hemispheres simultaneously from the first moment of each seizure — producing no focal aura, bilateral effects, and immediate full-intensity seizure. It is not one condition but a family of distinct syndromes each requiring different treatment. In India, as worldwide, focal epilepsy is more common overall, but generalised syndromes are a large and frequently misclassified group. The most critical fact: carbamazepine, phenytoin, and gabapentin can worsen JME and Dravet syndrome, yet carbamazepine and phenytoin are widely prescribed in India. A patient whose seizures worsen on these drugs almost certainly has an unidentified generalised epilepsy syndrome.
- What it is
- Both hemispheres seize simultaneously from seizure onset. No aura. Symmetric or bilateral effects. Family of syndromes — each needing different medication.
- Most common adult form (JME)
- Onset in adolescence · Morning arm jerks (drops objects at breakfast) · Tonic-clonic seizures after waking · 80–90% seizure freedom on valproate or levetiracetam · Lifelong condition.
- The carbamazepine problem
- Carbamazepine/phenytoin/gabapentin worsen JME, absence epilepsy, and Dravet syndrome. If seizures increased after starting these drugs in an unclassified patient: syndrome reassessment urgent at KIMS.
- Dravet syndrome (SCN1A)
- Begins in infancy with febrile seizures · SCN1A gene mutation (80%) · Sodium channel blockers cause catastrophic worsening and can trigger SE · SCN1A testing available at KIMS.
- LGS surgery
- Corpus callosotomy at KIMS: 70–80% reduction in drop attacks. Life-changing for children who fall multiple times daily. VNS also available.
- Medication safety table
- See the medication safety table in the Treatment section — which drugs are first-line and which actively worsen each syndrome.
- Contact KIMS
- 040-44885000 · Syndrome assessment · SCN1A testing · Ketogenic diet · Corpus callosotomy
| Fact | Details |
|---|---|
| What makes it generalised | Both hemispheres simultaneously · No focal onset · No aura · Symmetric effects · EEG: bilateral simultaneous spike-wave discharge |
| Most common syndromes | JME (most common adult) · Childhood Absence Epilepsy · Lennox-Gastaut · Dravet · West Syndrome · Progressive Myoclonic Epilepsies (Lafora disease prevalent in India) |
| India-specific | Focal epilepsy is more common overall in India; generalised syndromes are frequent in children and adolescents · Lafora disease elevated in consanguineous communities (EPM2A/EPM2B genes) |
| Critical drug warning | Carbamazepine · Phenytoin · Gabapentin — can worsen JME, Dravet, absence epilepsy · Carbamazepine and phenytoin widely prescribed in India · Syndrome reassessment urgent if seizures worsening on these |
| LGS surgery at KIMS | Corpus callosotomy — 70–80% reduction in drop attacks · VNS available · Ketogenic diet supervised by epilepsy dietitian |
| Dravet care at KIMS | SCN1A genetic testing · CBD and fenfluramine available · Ketogenic diet · VNS · Immediate sodium channel blocker discontinuation on positive result |
| Valproate in women | Teratogenic risk (neural tube defects, cognitive impairment in child) · Counselling mandatory and documented before starting in any girl/woman of childbearing age · Alternatives: levetiracetam, lamotrigine |
About This Condition
A Story That Happens Too Often in India
A 17 year old boy wakes up on a school morning, reaches for his phone, and drops it. His hand jerked just for a second. He has been doing this for months: dropping glasses of water at breakfast, occasionally stumbling when getting out of bed. His parents noticed but assumed it was clumsiness. One morning he has a full tonic clonic seizure in the bathroom and is taken to hospital.
He is diagnosed with epilepsy and started on carbamazepine, the most commonly available antiepileptic drug in most hospital formularies across India.
Three months later, his seizures are worse. He is now having more tonic clonic seizures than before, and the morning jerks have become more frequent. The dose is increased. Things get worse. A second drug is added.
What this boy has is Juvenile Myoclonic Epilepsy, or JME. The morning jerks, the teenage onset, the tonic clonic seizures, it is a textbook presentation. And carbamazepine is specifically contraindicated in JME. It does not fail to help. It actively worsens the condition. The drug is not wrong because it was prescribed carelessly. It is wrong because the syndrome was never identified and syndrome identification was never the priority.
This scenario plays out thousands of times every year across India. It is one of the most common, most correctable, and most harmful errors in epilepsy care.
Generalised epilepsy, in which seizures involve both brain hemispheres simultaneously, is common in India, particularly in children and adolescents, although focal epilepsy is more common overall. The majority of these patients can be completely seizure free, but only with the correct syndrome identified and the appropriate medication matched to it.
At KIMS Neuroscience, Secunderabad, Hyderabad, the first thing we do in every epilepsy consultation is precisely this: identify the syndrome. Not the seizure type. The syndrome. Because the syndrome tells us the medication, the prognosis, the genetic implications, and in the severe syndromes, the full treatment plan including surgery.
Book Epilepsy Consultation
Expert epilepsy diagnosis and treatment at KIMS Neuroscience Hyderabad.
040-44885000International enquiries: neuroscience@kimshospitals.comWhat Is Generalised Epilepsy?
In focal (partial) epilepsy, the abnormal electrical discharge starts in one specific area of one hemisphere of the brain and may or may not spread. In generalised epilepsy, the discharge involves both hemispheres simultaneously from the very first moment of the seizure.
Because both hemispheres are involved immediately, generalised seizures produce effects on both sides of the body or loss of consciousness without any focal onset. There is no aura. There is no warning signal. The seizure arrives at full intensity immediately.
Generalised epilepsy is not one condition. It is a category covering many distinct syndromes, each with its own age of onset, characteristic seizure types, EEG signature, genetic basis, medication requirements, and long term prognosis. Treating generalised epilepsy without identifying the specific syndrome is like treating an infection without knowing whether it is bacterial or viral. The broad category is a starting point, not a diagnosis.
The Generalised Seizure Types and What They Look Like
Tonic Clonic Seizure
Previously called grand mal seizures, tonic clonic seizures are the most dramatic and most recognisable seizure type. The body suddenly stiffens, the arms and legs become rigid, and the person may cry out as air is forced through the vocal cords. This is followed by rhythmic, symmetric jerking movements. The person is unconscious throughout the seizure.
After the seizure, the patient is typically confused, exhausted, and may sleep for hours. This postictal phase, the period of confusion and fatigue after the seizure, is one of the features that distinguishes a tonic clonic seizure from fainting.
Myoclonic Seizure
A myoclonic seizure is a sudden, brief, electric shock like jerk of the muscles, typically involving the arms, shoulders, or sometimes the whole body. These jerks last less than a second and the person remains fully conscious during the event.
In Juvenile Myoclonic Epilepsy (JME), these jerks occur in the morning within minutes of waking, causing patients to drop cups, spill tea, or stumble. Because the movements are so brief, they are frequently not recognised as seizures at all.
Absence Seizure
Absence seizures cause brief staring spells and short periods of unawareness. They are commonly seen in children and may initially be mistaken for daydreaming or inattentiveness. This condition is covered in detail on our dedicated Absence Seizures page.
Tonic Seizure
Tonic seizures involve sudden stiffening of the body without the rhythmic jerking phase seen in tonic clonic seizures. These seizures can cause sudden falls and injuries.
Atonic Seizure (Drop Attack)
Atonic seizures cause sudden, complete loss of muscle tone. The person collapses to the ground without warning, with no stiffening, jerking, or aura. Because these falls occur abruptly, the risk of serious head and facial injury is extremely high.
Helmets are sometimes necessary for protection. Drop attacks are the most disabling and dangerous seizure type in Lennox Gastaut syndrome.
Clonic Seizure
Clonic seizures cause repetitive, rhythmic jerking movements without the initial stiffening phase that characterises tonic clonic seizures.
Diagnosis at KIMS
The Major Generalised Epilepsy Syndromes KIMS Diagnoses and Treats
Juvenile Myoclonic Epilepsy (JME)
The most common adult generalised epilepsy syndrome
JME begins in adolescence, most commonly between ages 12 and 18, and is characterised by three seizure types that occur in a highly consistent pattern.
Morning myoclonic jerks are the first symptom in most patients, appearing months to years before diagnosis. They occur in the first hour after waking, causing patients to drop objects, spill drinks, or stumble. These jerks are almost never reported because they are not recognised as seizures.
Generalised tonic clonic seizures typically occur in the morning, after sleep deprivation, after alcohol, or with sudden awakening by an alarm. These are usually the seizures that finally bring JME patients to medical attention.
Absence seizures are present in approximately one third of JME patients.
The pattern is highly recognisable: adolescent onset, morning symptoms, and sleep deprivation as the dominant trigger. JME responds extremely well to the correct medication. Approximately 80–90% of patients achieve seizure freedom with valproate or levetiracetam.
Critical Medication Warning
Carbamazepine, phenytoin, oxcarbazepine, and gabapentin are contraindicated in JME. These medications are effective for focal epilepsy but can paradoxically worsen seizures in generalised epilepsy syndromes. Studies from India have specifically documented worsening seizure control in JME patients treated with carbamazepine and phenytoin.
JME is usually lifelong. Seizures frequently return if medication is stopped. At KIMS, patients receive detailed counselling about long term treatment, driving restrictions, and the risks of sudden medication withdrawal.
Childhood Absence Epilepsy (CAE)
Childhood Absence Epilepsy usually begins between ages 4 and 10. Children experience multiple brief staring spells every day, often mistaken for daydreaming or inattentiveness until EEG testing shows the classic 3Hz spike and wave discharge pattern.
The prognosis is excellent. Approximately 70% of children outgrow the condition by adolescence.
First line treatment is ethosuximide for pure absence seizures, while valproate or lamotrigine are alternatives. Carbamazepine can dramatically worsen absence seizures and must be avoided.
Juvenile Absence Epilepsy (JAE)
Juvenile Absence Epilepsy resembles Childhood Absence Epilepsy but begins later, typically between ages 10 and 17. Patients have fewer absence seizures per day but are much more likely to develop generalised tonic clonic seizures.
Remission rates are lower than in CAE and many patients continue to require treatment into adulthood. Valproate is preferred when tonic clonic seizures coexist, while lamotrigine is another important treatment option.
Lennox Gastaut Syndrome (LGS)
The most severe childhood generalised epilepsy syndrome
Lennox Gastaut Syndrome is a severe paediatric epilepsy syndrome characterised by mixed seizure types, cognitive decline, and slow spike wave EEG discharges below 3Hz. Atonic seizures produce dangerous drop attacks with high risk of injury.
LGS usually begins before age 4. Children experience multiple daily seizures including tonic, atonic, and absence like seizures along with intellectual disability and behavioural problems.
No single medication controls LGS. Treatment usually involves combination therapy using valproate, lamotrigine, clobazam, rufinamide, or topiramate. Cannabidiol oral solution is now an important adjunctive option in refractory cases.
For many families, the goal is not complete seizure freedom but reducing injuries, improving function, and preserving cognitive development as much as possible.
Surgical and Device Based Options at KIMS
Corpus callosotomy interrupts the spread of seizures between the two brain hemispheres and can reduce drop attacks by approximately 70–80%. For children who fall multiple times daily, this can be life changing.
Vagus Nerve Stimulation (VNS) reduces seizure frequency in approximately half of patients with drug resistant LGS and is available at KIMS.
The ketogenic diet is another important treatment option and is supervised at KIMS through a structured epilepsy diet programme.
Dravet Syndrome
A genetic epilepsy syndrome that must be identified early
Dravet syndrome is a severe developmental and epileptic encephalopathy, a condition in which the epilepsy itself damages brain development, not just as a side effect of seizures but as a direct consequence of the underlying genetic disruption.
Dravet syndrome is caused by mutations in the SCN1A gene which codes for the sodium channel protein Nav1.1 in approximately 80% of cases. The incidence is approximately 1 in 16,000 to 1 in 40,000 live births.
It begins in the first year of life typically with a prolonged febrile seizure in a previously healthy infant. Over the following years, multiple seizure types develop: generalised tonic-clonic, focal, myoclonic, and absence-like. Cognitive development slows. By school age, most children with Dravet syndrome have intellectual disability, behaviour problems, and highly treatment-resistant seizures.
The medication danger in Dravet syndrome
The current consensus of seizure management in Dravet syndrome consists of specific combinations of conventional and recently approved drugs including valproate, clobazam, stiripentol, cannabidiol, and fenfluramine. Critically sodium channel-blocking medications carbamazepine, oxcarbazepine, lamotrigine, and phenytoin worsen Dravet syndrome dramatically. These drugs block the sodium channels that are already dysfunctional in Dravet. Giving them can cause status epilepticus and acute neurological deterioration.
This is why genetic testing for SCN1A is critically important whenever Dravet syndrome is suspected. A positive SCN1A result at KIMS immediately triggers the correct medication protocol and the immediate discontinuation of any sodium channel blockers. In India, where carbamazepine is the default first-line prescription in many settings, finding an undiagnosed Dravet patient on carbamazepine worsening daily is a genuine clinical emergency.
At KIMS: SCN1A genetic testing is offered to every child with suspected Dravet syndrome. Cannabidiol (CBD) and fenfluramine are available through appropriate channels. The ketogenic diet is supervised by our dedicated dietitian. VNS implantation is available for drug-refractory cases.
Other Generalised Epilepsy Syndromes Seen at KIMS
West Syndrome (Infantile Spasms)
West syndrome begins during the first year of life and causes clusters of infantile spasms in which the baby's head suddenly drops forward while the arms extend outward. EEG shows the characteristic hypsarrhythmia pattern. Early treatment with ACTH or vigabatrin is critical because delays are associated with worse developmental outcomes.
Progressive Myoclonic Epilepsies (PMEs)
A group of rare, hereditary conditions including Lafora disease, Unverricht-Lundborg disease, and Neuronal Ceroid Lipofuscinosis in which myoclonic epilepsy is combined with neurological deterioration over time. India has a specific burden of Lafora disease, a condition caused by recessive mutations in EPM2A or EPM2B genes, with a high prevalence in communities with consanguinity. Genetic testing, family screening, and management of both seizures and the progressive neurological decline are provided at KIMS.
Benign Neonatal and Infantile Epilepsies
Self-limited genetic epilepsies in neonates and infants including Benign Familial Neonatal Epilepsy (KCNQ2) and Benign Familial Infantile Epilepsy which typically resolve spontaneously without long-term consequences. Accurate diagnosis prevents unnecessary long-term medication.
Diagnosis — How Generalised Epilepsy Is Confirmed at KIMS
Generalised epilepsies are diagnosed through a combination of clinical history, EEG patterns, neuroimaging, and genetic testing. In most cases, the syndrome itself is identified from the clinical story supported by electrophysiology.
Step 1 — Clinical History: The Syndrome Is Usually in the Story
A structured clinical history is the most powerful diagnostic tool. Juvenile Myoclonic Epilepsy (JME) is often diagnosed from history alone, based on adolescent onset, morning myoclonic jerks, and clear triggers. Dravet syndrome is suspected from fever-triggered infantile seizures, developmental slowing, and poor response to standard medications. Key questions include: time of seizures, triggers, brief unnoticed jerks, and exact age of onset.
Step 2 — EEG: The Electrical Signature of the Syndrome
EEG is essential and often diagnostic. JME shows generalised polyspike-and-wave discharges, especially during drowsiness and sleep deprivation. Childhood Absence Epilepsy shows 3 Hz spike-and-wave triggered by hyperventilation. Lennox-Gastaut syndrome shows slow spike-and-wave (<2.5 Hz) with additional fast activity. Dravet syndrome may have a normal EEG early, later evolving to generalised and focal discharges with photosensitivity.
Step 3 — MRI Brain
Most idiopathic generalised epilepsies such as JME, CAE, and JAE have a normal MRI, as they are genetic rather than structural. MRI is still performed to exclude structural causes. In Lennox-Gastaut syndrome, MRI may reveal cortical malformations, hypoxic injury, or tuberous sclerosis. In Dravet syndrome, MRI is usually normal in early stages.
Step 4 — Genetic Testing
Genetic testing is increasingly important in paediatric epilepsy. At KIMS, SCN1A testing is done for suspected Dravet syndrome. Broad epilepsy gene panels are used for unexplained Lennox-Gastaut syndrome or developmental epileptic encephalopathies. PME panels include genes such as EPM2A and EPM2B for Lafora disease. West syndrome of unknown cause is evaluated with multigene panels. Genetic diagnosis confirms syndrome, guides medication choice, and helps genetic counselling.
Step 5 — Neuropsychological Assessment
Children with Lennox-Gastaut syndrome, Dravet syndrome, West syndrome, and other developmental epileptic encephalopathies undergo formal neuropsychological evaluation. This assesses cognition, language, and adaptive functioning. It helps define baseline function, guides educational planning, and tracks progression or response to treatment over time.
Treatment
Treatment at KIMS — Syndrome-Specific Medication Protocols
The KIMS approach is explicit and syndrome-specific. In generalised epilepsy, medication choice is critical because the wrong drug can significantly worsen seizures. Treatment protocols are selected based on the exact epilepsy syndrome rather than simply the seizure type.
Syndrome | First-line Medication | Actively Avoid |
|---|---|---|
Juvenile Myoclonic Epilepsy (JME) | Valproate · Levetiracetam · Lamotrigine | Carbamazepine · Phenytoin · Oxcarbazepine · Gabapentin |
Childhood Absence Epilepsy | Ethosuximide · Valproate · Lamotrigine | Carbamazepine · Phenytoin |
Lennox-Gastaut Syndrome | Valproate + Lamotrigine + Clobazam | Carbamazepine alone as monotherapy |
Dravet Syndrome | Valproate + Clobazam + Stiripentol/CBD | Carbamazepine · Oxcarbazepine · Lamotrigine · Phenytoin |
West Syndrome | ACTH or vigabatrin urgently | Delay — every month matters |
Valproate in Women and Girls — A Critical Counselling Point
Valproate is highly effective for Juvenile Myoclonic Epilepsy, generalised epilepsy, and Lennox-Gastaut syndrome. However, it carries a major teratogenic risk. Exposure during pregnancy is associated with neural tube defects, cognitive impairment in the child, and increased risk of autistic spectrum disorder.
In India, many adolescent girls with JME are started on valproate without receiving structured counselling regarding future pregnancy risks. At KIMS, this counselling is mandatory and documented before initiating treatment in any girl or woman of childbearing age.
Counselling includes detailed discussion about teratogenic risk, need for effective contraception while on valproate, pregnancy planning before conception, and alternative medication options when appropriate. This is considered a standard safety requirement at KIMS and is not optional.
Surgical and Non-Medical Treatment Options at KIMS
Corpus Callosotomy — for Drop Attacks in LGS
Corpus callosotomy is one of the most meaningful surgical interventions available for Lennox-Gastaut syndrome and other generalised epilepsies with atonic seizures. By dividing the corpus callosum the band of fibres connecting the brain's two hemispheres the procedure interrupts the rapid spread of seizure activity across the brain, dramatically reducing the frequency of the bilateral synchronised discharges that cause drop attacks.
Results at specialist centres consistently show 70–80% reduction in atonic drop attacks after corpus callosotomy. For a child who has been falling and injuring their head multiple times a day, this is a life-changing reduction removing the need for constant supervision, allowing school attendance, and dramatically improving quality of life for the whole family. the KIMS team performs corpus callosotomy at KIMS as part of the epilepsy surgery programme.
Vagus Nerve Stimulation (VNS) — for Drug-Resistant Generalised Epilepsy
VNS is an implantable device, a pulse generator placed under the skin of the chest, connected to the left vagus nerve in the neck by a wire under the skin. Regular electrical pulses are delivered to the vagus nerve, which modulates brain excitability through widespread neural connections. VNS reduces seizure frequency by at least 50% in approximately half of patients who receive it across multiple epilepsy syndromes including LGS, JME with drug resistance, and other generalised epilepsies.
VNS implantation is a short surgical procedure under general anaesthesia, typically with a one-night hospital stay. The device is adjusted non-invasively at clinic visits. It does not replace medication but reduces the overall seizure burden in patients for whom medications alone are insufficient. VNS is available at KIMS.
Ketogenic Diet Programme
The ketogenic diet very high in fat, very low in carbohydrates shifts the brain's primary fuel source from glucose to ketone bodies. This metabolic shift reduces seizure frequency through mechanisms not fully understood, but consistently documented in clinical trials. It is particularly effective in:
• Dravet syndrome one of the best-evidenced dietary treatments
• Lennox-Gastaut syndrome
• Glucose transporter type 1 (GLUT-1) deficiency where it is essentially curative
• ACTH-refractory West syndrome
The ketogenic diet requires intensive family commitment, careful dietary management, and regular biochemical monitoring. At KIMS, the ketogenic diet programme is supervised by a dedicated epilepsy dietitian and the paediatric neurology team. Families receive detailed training, written food guides adapted for Indian cuisine and ingredient availability, and structured follow-up every 3 months.
Living with Generalised Epilepsy School Work Driving and Family
JME a lifelong but manageable condition For JME patients on the right medication seizure freedom is achievable but the condition is typically lifelong Attempts to stop medication after a seizure free period result in relapse in approximately 90% of patients At KIMS patients are advised :
• Take medication at the same time every day consistency matters more in JME than in many other epilepsy types
• Prioritise sleep sleep deprivation is the most powerful seizure trigger in JME
• Avoid or moderate alcohol a common precipitant in young adult JME patients
• Know your legal position on driving seizure free for two years required by Indian law
• Plan pregnancy in advance valproate requires contraception and pre conception counselling
For children with LGS and Dravet syndrome Both syndromes require educational support planning Schools must be informed in writing from KIMS about the seizure types the risk of drop attacks what to do during a seizure and the emergency medication plan KIMS provides school liaison letters for every child with a significant epilepsy syndrome
Helmet use for children with frequent drop attacks protects against the most common injury mechanism in LGS We provide written recommendations for appropriate helmet specifications
Carer training in the use of rescue medication buccal midazolam or rectal diazepam for use when a seizure lasts more than 5 minutes is provided to all families at KIMS before discharge
Related Conditions
Explore related epilepsy and seizure disorders commonly associated with generalised epilepsy syndromes:
FAQs
Frequently Asked Questions
Your epilepsy may be a specific syndrome — and the wrong medication for your syndrome is making it worse.
At KIMS Neuroscience, Secunderabad, every epilepsy consultation begins with syndrome identification because the correct treatment for JME is different from Lennox-Gastaut, and both are different from Dravet syndrome. If seizures are uncontrolled, if medication changes haven't helped, or if you've never been told what specific type of epilepsy you have, a KIMS consultation is the starting point.
neuroscience@kimshospitals.com